Cynthia V Pagba

Title: Innovations of Cynthia V Pagba in Cancer Therapeutics.

Introduction

Cynthia V Pagba is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of cancer therapeutics through her innovative research and development of KRAS inhibitors. With a total of 2 patents, her work is paving the way for new treatment options in oncology.

Latest Patents

Cynthia's latest patents focus on methods and compositions for KRAS inhibitors. These compounds are allosteric inhibitors of KRAS, which are extremely useful for therapeutic intervention in various disorders and diseases, particularly cancer. The disclosed compounds include substituted 7-(piperazin-1-yl)pyrazolo[1,5-a]pyrimidine analogs. Furthermore, these compounds can be utilized in methods of treating cancer, showcasing their potential in clinical applications.

Career Highlights

Cynthia V Pagba is affiliated with the University of Texas System, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Cynthia collaborates with esteemed colleagues, including Alemayehu Gorfe Abebe and Michael J McCarthy. These partnerships enhance her research capabilities and contribute to the advancement of her projects.

Conclusion

Cynthia V Pagba's contributions to the field of cancer therapeutics through her innovative patents highlight her role as a leading inventor. Her work on KRAS inhibitors represents a significant advancement in the fight against cancer, offering hope for improved treatment options.